162 related articles for article (PubMed ID: 36745299)
1. Inverse Relationship Between Clock Gene Expression and Inflammatory Markers in Ulcerative Colitis Patients Undergoing Remission.
Weintraub Y; Cohen S; Anafy A; Chapnik N; Tsameret S; Ben-Tov A; Yerushalmy-Feler A; Dotan I; Tauman R; Froy O
Dig Dis Sci; 2023 Jun; 68(6):2454-2462. PubMed ID: 36745299
[TBL] [Abstract][Full Text] [Related]
2. Clock Gene Disruption Is an Initial Manifestation of Inflammatory Bowel Diseases.
Weintraub Y; Cohen S; Chapnik N; Ben-Tov A; Yerushalmy-Feler A; Dotan I; Tauman R; Froy O
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):115-122.e1. PubMed ID: 30981000
[TBL] [Abstract][Full Text] [Related]
3. Mucosal Genes Encoding Clock, Inflammation and Their Mutual Regulators Are Disrupted in Pediatric Patients with Active Ulcerative Colitis.
Labes S; Froy O; Tabach Y; Shamir R; Shouval DS; Weintraub Y
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338765
[TBL] [Abstract][Full Text] [Related]
4. Correlations between the symptoms of insomnia, depression, sleep quality, antitumor necrosis factor therapy, and disrupted circadian clock gene expression in inflammatory bowel disease.
Sochal M; Binienda A; Ditmer M; Małecka-Wojciesko E; Białasiewicz P; Fichna J; Talar-Wojnarowska R; Gabryelska A
Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 37154720
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.
Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T
Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210
[TBL] [Abstract][Full Text] [Related]
6. Circadian clock gene disruption in white blood cells of patients with celiac disease.
Weintraub Y; Cohen S; Yerushalmy-Feler A; Chapnik N; Tsameret S; Anafy A; Damari E; Ben-Tov A; Shamir R; Froy O
Biochimie; 2024 Apr; 219():51-54. PubMed ID: 37524198
[TBL] [Abstract][Full Text] [Related]
7. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
9. Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease.
Swaminathan A; Borichevsky GM; Edwards TS; Hirschfeld E; Mules TC; Frampton CMA; Day AS; Hampton MB; Kettle AJ; Gearry RB
J Crohns Colitis; 2022 Dec; 16(12):1862-1873. PubMed ID: 35803583
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome.
Palmieri O; Mazzoccoli G; Bossa F; Maglietta R; Palumbo O; Ancona N; Corritore G; Latiano T; Martino G; Rubino R; Biscaglia G; Scimeca D; Carella M; Annese V; Andriulli A; Latiano A
Chronobiol Int; 2015; 32(7):903-16. PubMed ID: 26172092
[TBL] [Abstract][Full Text] [Related]
11. Complex changes of circadian proteins expression in inflammatory bowel disease.
Mosna K; Janega P; Sedlak J; Babal P
Bratisl Lek Listy; 2021; 122(4):235-241. PubMed ID: 33729814
[TBL] [Abstract][Full Text] [Related]
12. Prediction of treatment outcome and relapse in inflammatory bowel disease.
Kato J; Yoshida T; Hiraoka S
Expert Rev Clin Immunol; 2019 Jun; 15(6):667-677. PubMed ID: 30873890
[TBL] [Abstract][Full Text] [Related]
13. Serum galectins as potential biomarkers of inflammatory bowel diseases.
Yu TB; Dodd S; Yu LG; Subramanian S
PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
[TBL] [Abstract][Full Text] [Related]
14. Urgency for bowel movements is a highly discriminatory symptom of active disease in persons with IBD (the Manitoba Living with IBD study).
Kulyk A; Shafer LA; Graff LA; Stone J; Witges K; Targownik LE; Bernstein CN
Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1570-1580. PubMed ID: 36225106
[TBL] [Abstract][Full Text] [Related]
15. GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD.
Dierckx T; Verstockt B; Vermeire S; van Weyenbergh J
J Crohns Colitis; 2019 Mar; 13(3):389-394. PubMed ID: 30312386
[TBL] [Abstract][Full Text] [Related]
16. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
18. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
19. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
20. Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients.
Nunes T; Etchevers MJ; Sandi MJ; Pinó Donnay S; Grandjean T; Pellisé M; Panés J; Ricart E; Iovanna JL; Dagorn JC; Chamaillard M; Sans M
PLoS One; 2014; 9(1):e84957. PubMed ID: 24416322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
